Please ensure Javascript is enabled for purposes of website accessibility

Why ExxoMobil, Chevron, and CarMax Stocks Surged Today

By Rich Smith - Apr 17, 2020 at 6:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Will a new drug end the coronavirus quarantine and send Americans back to work?

What happened

Gilead Sciences' (NASDAQ:GILD) antiviral medication remdesivir set stock markets on fire Friday, sending the S&P 500 hurtling 2.7% higher by close of trading.

Some of the stocks making the biggest gains today included oil majors ExxonMobil (XOM -2.58%) and Chevron (CVX -0.98%), closing 10.4% and 9% higher, respectively. But energy companies weren't the only ones notching big gains. CarMax (KMX -3.54%) was up 10.4% by the closing bell.

Sign saying a business is closed due to COVID-19

Image source: Getty Images.

So what

So what's the connection here? Oil prices, after all, are in a tailspin, and the price of WTI crude oil in particular fell nearly 9% in trading today. What could it be that's offsetting this clearly negative news for oil producers -- and boosting the stock of a car dealer at the same time?  

Gilead's antiviral, which seems to be demonstrating efficacy in quickly curing patients of the virus, combined with President Trump's announcement last night of his Opening Up America Again plan for business, has investors thinking that the nation's self-imposed quarantine might be nearing an end.  

If there's a drug out there to quickly quash the coronavirus, and if the president thinks it might be good enough to begin opening up the economy again, then this implies that stay-at-home orders might soon be lifted, and Americans might soon be permitted to return to their office and factory jobs.

Now what

It doesn't take too great a leap in logic to think that workers going back to work will mean they'll be buying cars to get them to work, and that they'll be needing gasoline to fuel those cars. The next logical conclusion: The stocks of car dealers and oil companies will benefit from this development.

But even if Gilead's remdesivir turns out to be the silver bullet that kills the coronavirus (yet to be proven), and even if various state and local governments begin permitting people to go back to work, at this point, would you face the risk of contracting a life-threatening disease in the hope that a barely tested treatment will save you?

I didn't think so.

Although the prospect of a cure for COVID-19 is certainly reassuring, the prospect of contracting it is probably the primary concern for most people. I wonder, therefore, if Americans will be as eager to return to the office or factory (and the close contact with co-workers) quite so quickly as investors seem to be assuming today.

Call me a skeptic, but we may still be quite some time away from the end of our national crisis.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Exxon Mobil Corporation Stock Quote
Exxon Mobil Corporation
XOM
$85.85 (-2.58%) $-2.27
Chevron Corporation Stock Quote
Chevron Corporation
CVX
$145.54 (-0.98%) $-1.44
CarMax Inc. Stock Quote
CarMax Inc.
KMX
$90.26 (-3.54%) $-3.31

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
317%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.